Troluce Capital Advisors »

Edgewise Therapeutics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $892k 55k 16.22

More positions owned by Troluce Capital Advisors

Fluor Corporation Call Option (FLR)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Kenvue (KVUE)
Honeywell International Call Option (HON)
Echostar Corp Cl A (SATS)
Capital One Financial (COF)
Dupont De Nemours (DD)
Oklo Com Cl A Put Option (OKLO)
Golar Lng SHS Call Option (GLNG)
EXACT Sciences Corporation Call Option (EXAS)
Amcor Ord (AMCR)
Standardaero (SARO)
Intel Corporation Call Option (INTC)
Equinix (EQIX)
U Haul Holding Company Com Ser N (UHAL.B)

View all positions for Troluce Capital Advisors

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Baker Bros. Advisors
BlackRock
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Henderson Group
Vanguard Group
Cormorant Asset Management
Siren
Perceptive Advisors
Bellevue Group
Driehaus Capital Management
MPM Oncology Impact Management

View all funds holding Edgewise Therapeutics